Skip to content

Effect of Virtual Reality and Shot Blocker for Managing Pain, Anxiety, and Vital Signs

A Comparative Study of Virtual Reality and Shot Blocker Maneuver for Managing Pain, Anxiety, and Vital Signs in Patients During Bone Marrow Aspiration and Biopsy: Randomized Controlled Trail

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230310057672N6
Enrollment
223
Registered
2025-01-29
Start date
2025-02-06
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pain. Condition 2: Anxiety. Condition 3: Changes in vital signs. Condition 4: Vital signs: heart rate. Condition 5: Vital signs: Heart rate. Condition 6: Vital signs: Breathing rate. Pain, not elsewhere classified Anxiety disorder due to known physiological condition Encounter for examination of blood pressure Tachycardia, unspecified Bradycardia, unspecified Abnormalities of breathing

Interventions

Intervention 1: Intervention group (A): virtual reality (VR) technology only, this group received virtual reality technology using Samsung gear VR The patient is placed in the prone position and the v

Sponsors

University of Baghdad/College of Nursing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adult patient with undergoing bone marrow aspiration and biopsy local anesthetic, having no experience of bone marrow aspiration and biopsy Full consciousness No hearing and vision impairments based on the patient’s report.

Exclusion criteria

Exclusion criteria: The patient’s withdrawal at any stage of the study Not using a VR headset during bone marrow aspiration and biopsy Developing clinical instability during the procedure (such as loss of conscious- ness, cardiac and respiratory disorders, nausea, oculomotor issues).

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Five minutes before bone marrow aspiration - immediately after bone marrow aspiration. Method of measurement: stat-trait anxiety scale (STAS).;Changes in vital signs. Timepoint: Five minutes before bone marrow aspiration - during bone marrow aspiration - 5 minutes after bone marrow aspiration. Method of measurement: Portable monitor device.

Secondary

MeasureTime frame
Pain. Timepoint: Immediately after bone marrow aspiration and biopsy. Method of measurement: Visual analog scale (VAS) The VAS is a reliable, valid, responsive, and frequently used pain outcome measure. It consists of a bidirectional 10 cm straight line with two labels, that is, “no pain” and “worst possible pain”, located at either end of the line. Patients are instructed to draw a vertical mark on the line indicating their pain level The reliability data are VAS, (0.97). whereas (0) means no pain, the closer you are to number (10) means sever pain.;Anxiety. Timepoint: Immediately after bone marrow aspiration and biopsy. Method of measurement: Stat-trait anxiety scale (STAS) The 20-item SAI and the 20-item Trait Anxiety Inventory are independent of each other. In SAI, each item is scored in four-point Likert-type responses as follows: none: 1, a little: 2, a lot: 3, and completely: 4. In the Trait Anxiety Inventory, each item is scored in four-point Likert-type responses: rarely: 1, sometimes: 2, most of the time: 3, and almost always: 4. Higher scores indicate a higher level of anxiety, whereas low scores indicate that the anxiety level is low. In this study, Cronbach’s alpha value of the state anxiety inventory was found to be 0.937.;Vital signs (HR, BP, RR and SPo2) during procedure. Timepoint: Immediately after bone marrow aspiration and biopsy. Method of measurement: Portable monitor device: Vital signs are measured during and immediate after bone marrow aspiration and biopsy ( Patient's device manufacturer: Comen Magic Country: India Model: C86 Serial Number Kf200723063f).

Countries

Iraq

Contacts

Public ContactAlaa Jawad Kadhim

University of Baghdad/college of Nursing

alaaj@conursing.uobaghdad.edu.iq+964 770 352 0314

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026